Fundraising Fox
🦊/Companies
Sign in

EVerZom

Paris, FR · 1 known investors

Find your way into EVerZom

EVerZom develops exosome formulation technologies that modify cells to release exosomes with enhanced therapeutic properties, designed for targeted delivery to specific tissue sites. The company creates formulated exosome drugs for treating pathologies through local or systemic administration routes.

BiotechDeep TechHealthtechMedical Devices

Investors · 1

Capital CellBarcelona

In the news

EVerZom Raises €10M in Fundingfinsmes.com · Oct 2025EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseasesglobenewswire.com · Oct 2025EVerZom raises €1.1M to industrialize its exosome biomanufacturing platform | BioBuzzbiobuzz.io · Dec 2024Winner of the European EIC Accelerator program, EVerZom accelerates the industrialization of its exosome bioproduction platform for regenerative medicine | BioInformantbioinformant.com · Dec 2021EVerZom Raises €1.1M in Funding - FinSMEsfinsmes.com · Dec 2020French Biotech EVerZom Raises €10 Million to Launch First Clinical Trial of Exosome Therapy EVerGel™biopharmaboardroom.com

Frequently asked questions

What does EVerZom do?
EVerZom develops exosome formulation technologies that modify cells to release exosomes with enhanced therapeutic properties, designed for targeted delivery to specific tissue sites. The company creates formulated exosome drugs for treating pathologies through local or systemic administration routes.
Who are EVerZom's investors?
EVerZom's investors include Capital Cell.
Where is EVerZom headquartered?
EVerZom is headquartered in Paris, FR.